Pharmacological characterization of zinc and copper interaction with the human alpha1A-adrenoceptor

European Journal of Pharmacology

Volumn 655, Issue 1-3, 2011, Pages 1-8

  Ciolek, Justyna ^a,b   Maïga, Arhamatoulaye ^a   Marcon, Elodie ^a   Servent, Denis ^a   Gilles, Nicolas ^a  

^a SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

1 adrenoceptor; Binding experiments; Copper; Functional tests; Insurmountable antagonist; Prostate; Zinc

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ADRENALIN; ALPHA 1A ADRENERGIC RECEPTOR; COPPER ION; PRAZOSIN; ZINC ION;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CELL FUNCTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; LIGAND BINDING; METAL BINDING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; CERCOPITHECUS AETHIOPS; COPPER; COS CELLS; HUMANS; KINETICS; PRAZOSIN; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-1; ZINC;

EID: 79952534784     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.12.042     Document Type: Article

References (48)

1. A. Alcaraz, P. Hammerer, A. Tubaro, F.H. Schroder, and R. Castro Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review Eur. Urol. 55 2008 864 873
2. K.E. Andersson, and P. Hedlund Pharmacologic perspective on the physiology of the lower urinary tract Urology 60 2002 13 20 discussion 20-11
3. C.M. Benning, and N. Kyprianou Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor- independent action Cancer Res. 62 2002 597 602 (Pubitemid 34106437)
4. N.J. Birdsall, F. Cohen, S. Lazareno, and H. Matsui Allosteric regulation of G-protein-linked receptors Biochem. Soc. Trans. 23 1995 108 111
5. T.L. Bullock, and G.L. Andriole Jr. Emerging drug therapies for benign prostatic hyperplasia Expert Opin. Emerg. Drugs 11 2006 111 123
6. N. Calloway, D. Holowka, and B. Baird A basic sequence in STIM1 promotes Ca2+ influx by interacting with the C-terminal acidic coiled coil of Orai1 Biochemistry 49 2010 1067 1071
7. Y. Cheng, and W.H. Prusoff Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
8. L.C. Costello, R.B. Franklin, P. Feng, M. Tan, and O. Bagasra Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States) Cancer Causes Control 16 2005 901 915 (Pubitemid 41191416)
9. W.C. de Groat Integrative control of the lower urinary tract: preclinical perspective Br. J. Pharmacol. 147 Suppl 2 2006 S25 S40
10. A. Draguhn, T.A. Verdorn, M. Ewert, P.H. Seeburg, and B. Sakmann Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+ Neuron 5 1990 781 788
11. F.J. Ehlert Analysis of allosterism in functional assays J. Pharmacol. Exp. Ther. 315 2005 740 754 (Pubitemid 41500740)
12. P. Feng, T.L. Li, Z.X. Guan, R.B. Franklin, and L.C. Costello Effect of zinc on prostatic tumorigenicity in nude mice Ann. NY Acad. Sci. 1010 2003 316 320 (Pubitemid 38264997)
13. C.J. Frederickson, S.W. Suh, D. Silva, C.J. Frederickson, and R.B. Thompson Importance of zinc in the central nervous system: the zinc-containing neuron J. Nutr. 130 2000 1471S 1483S (Pubitemid 30244148)
14. A. Gore, A. Moran, M. Hershfinkel, and I. Sekler Inhibitory mechanism of store-operated Ca2+ channels by zinc J. Biol. Chem. 279 2004 11106 11111 (Pubitemid 38401603)
15. J.N. Guntupalli, S. Padala, A.V. Gummuluri, R.K. Muktineni, S.R. Byreddy, L. Sreerama, P.C. Kedarisetti, D.P. Angalakuduru, B.R. Satti, V. Venkatathri, V.B. Pullela, and S. Gavarasana Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique Eur. J. Cancer Prev. 16 2007 108 115
16. A.M. Harris, B.W. Warner, J.M. Wilson, A. Becker, R.G. Rowland, W. Conner, M. Lane, K. Kimbler, E.B. Durbin, A.T. Baron, and N. Kyprianou Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study J. Urol. 178 2007 2176 2180 (Pubitemid 47538576)
17. D.A. Horstman, S. Brandon, A.L. Wilson, C.A. Guyer, E.J. Cragoe Jr., and L.E. Limbird An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium J. Biol. Chem. 265 1990 21590 21595 (Pubitemid 120014201)
18. S. Jain, K. Sharma, and V. Sharma Serum and tissue levels of zinc, copper, magnesium and retinol in prostatic neoplasms India J. Clin. Biochem. 9 1994 106
19. T. Kenakin A Pharmacology Primer: Theory, Application, and Methods 2009 Elsevier Academic Press London
20. Y. Kojima, S. Sasaki, H. Shinoura, Y. Hayashi, G. Tsujimoto, and K. Kohri Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients Prostate 66 2006 761 767
21. T.A. Koshimizu, A. Tanoue, A. Hirasawa, J. Yamauchi, and G. Tsujimoto Recent advances in alpha1-adrenoceptor pharmacology Pharmacol. Ther. 98 2003 235 244
22. N. Kyprianou Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance J. Urol. 169 2003 1520 1525 (Pubitemid 36323836)
23. B. Laube, J. Kuhse, N. Rundstrom, J. Kirsch, V. Schmieden, and H. Betz Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors J. Physiol. 483 Pt 3 1995 613 619
24. S. Lazareno Determination of allosteric interactions using radioligand-binding techniques Meth. Mol. Biol. 259 2004 29 46
25. S. Lazareno, and N.J. Birdsall Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors Mol. Pharmacol. 48 1995 362 378
26. M.F. Leitzmann, M.J. Stampfer, K. Wu, G.A. Colditz, W.C. Willett, and E.L. Giovannucci Zinc supplement use and risk of prostate cancer J. Natl Cancer Inst. 95 2003 1004 1007 (Pubitemid 36896718)
27. R.A. Leppik, A. Mynett, S. Lazareno, and N.J. Birdsall Allosteric interactions between the antagonist prazosin and amiloride analogs at the human alpha(1A)-adrenergic receptor Mol. Pharmacol. 57 2000 436 445 (Pubitemid 30140872)
28. L.E. Limbird GTP and Na+ modulate receptor-adenyl cyclase coupling and receptor-mediated function Am. J. Physiol. 247 1984 E59 E68
29. Y. Liu, M.M. Teeter, C.J. DuRand, and K.A. Neve Identification of a Zn2+-binding site on the dopamine D2 receptor Biochem. Biophys. Res. Commun. 339 2006 873 879 (Pubitemid 41772895)
30. H.J. Motulsky, and P.A. Insel Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding. J. Biol. Chem. 258 1983 3913 3919 (Pubitemid 13052882)
31. V. Mutafova-Yambolieva, D. Staneva-Stoytcheva, L. Lasova, and R. Radomirov Effects of subchronic exposure of rats to lead or zinc on alpha-adrenoceptor-mediated contractile responses in isolated vas deferens Acta Physiol. Pharmacol. Bulg. 19 1993 111 119 (Pubitemid 24092614)
32. K. Nasu, N. Moriyama, K. Kawabe, G. Tsujimoto, M. Murai, T. Tanaka, and J. Yano Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue Br. J. Pharmacol. 119 1996 797 803 (Pubitemid 26366469)
33. H. Ozmen, F.A. Erulas, F. Karatas, A. Cukurovali, and O. Yalcin Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer Clin. Chem. Lab. Med. 44 2006 175 179 (Pubitemid 43237961)
34. A.B. Parekh Store-operated CRAC channels: function in health and disease Nat. Rev. Drug Discov. 9 2010 399 410
35. L. Quinton, E. Girard, A. Maiga, M. Rekik, P. Lluel, G. Masuyer, M. Larregola, C. Marquer, J. Ciolek, T. Magnin, R. Wagner, J. Molgo, R. Thai, C. Fruchart-Gaillard, G. Mourier, J. Chamot-Rooke, A. Menez, S. Palea, D. Servent, and N. Gilles Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor Br. J. Pharmacol. 159 2010 316 325
36. J.A. Schetz, A. Chu, and D.R. Sibley Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms J. Pharmacol. Exp. Ther. 289 1999 956 964 (Pubitemid 29191254)
37. J.A. Schetz, and D.R. Sibley Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors J. Neurochem. 68 1997 1990 1997 (Pubitemid 27176135)
38. C. Selvam, N. Oueslati, I.A. Lemasson, I. Brabet, D. Rigault, T. Courtiol, S. Cesarini, N. Triballeau, H.O. Bertrand, C. Goudet, J.P. Pin, and F.C. Acher A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists J. Med. Chem. 53 2010 2797 2813
39. M.R. Shah, C.L. Kriedt, N.H. Lents, M.K. Hoyer, N. Jamaluddin, C. Klein, and J. Baldassare Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer J. Exp. Clin. Cancer Res. 28 2009 84
40. G. Swaminath, T.W. Lee, and B. Kobilka Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor J. Biol. Chem. 278 2003 352 356 (Pubitemid 36043583)
41. G. Swaminath, J. Steenhuis, B. Kobilka, and T.W. Lee Allosteric modulation of beta2-adrenergic receptor by Zn(2+) Mol. Pharmacol. 61 2002 65 72 (Pubitemid 34049513)
42. V. Sydorenko, Y. Shuba, S. Thebault, M. Roudbaraki, G. Lepage, N. Prevarskaya, and R. Skryma Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells J. Physiol. 548 2003 823 836 (Pubitemid 36603302)
43. S. Thebault, M. Roudbaraki, V. Sydorenko, Y. Shuba, L. Lemonnier, C. Slomianny, E. Dewailly, J.L. Bonnal, B. Mauroy, R. Skryma, and N. Prevarskaya Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells J. Clin. Invest. 111 2003 1691 1701 (Pubitemid 38063111)
44. V. Tiwari, A. Agrawal, S. Mohd, and V. agrawal Comparative study of zinc levels in benign and maligant lesions of prostate India J. Surg. 66 2004 352
45. A. Traboulsie, J. Chemin, M. Chevalier, J.F. Quignard, J. Nargeot, and P. Lory Subunit-specific modulation of T-type calcium channels by zinc J. Physiol. 578 2007 159 171 (Pubitemid 44971117)
46. P.D. Walden, C. Gerardi, and H. Lepor Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate J. Urol. 161 1999 635 640
47. M. Yan, D.L. Liu, Y.L. Chua, C. Chen, and Y.L. Lim Effects of micromolar concentrations of manganese, copper, and zinc on alpha1-adrenoceptor-mediating contraction in rat aorta Biol. Trace Elem. Res. 82 2001 159 166 (Pubitemid 32990041)
48. V. Zaichick, T.V. Sviridova, and S.V. Zaichick Zinc in the human prostate gland: normal, hyperplastic and cancerous Int. Urol. Nephrol. 29 1997 565 574 (Pubitemid 27489811)